Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 More aggressive prostate cancer in elderly men.

Literature DB >> 24659918

More aggressive prostate cancer in elderly men.

Annelies Vellekoop¹, Stacy Loeb¹.

Abstract

Entities: Disease Species

Year: 2013 PMID： 24659918 PMCID： PMC3922326

Source DB: PubMed Journal: Rev Urol ISSN： 1523-6161

× No keyword cloud information.

9 in total

1. Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes.

Authors: Stephen A Brassell; Kevin R Rice; Patrick M Parker; Yongmei Chen; James S Farrell; Jennifer Cullen; David G McLeod
Journal: J Urol Date: 2010-11-12 Impact factor: 7.450

2. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.

Authors: Emil Scosyrev; Edward M Messing; Supriya Mohile; Dragan Golijanin; Guan Wu
Journal: Cancer Date: 2011-10-17 Impact factor: 6.860

3. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.

Authors: William J Catalona; Anthony V D'Amico; William F Fitzgibbons; Omofolasade Kosoko-Lasaki; Stephen W Leslie; Henry T Lynch; Judd W Moul; Marc S Rendell; Patrick C Walsh
Journal: Ann Intern Med Date: 2012-07-17 Impact factor: 25.391

4. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.

Authors: Jason C Massengill; Leon Sun; Judd W Moul; Hongyu Wu; David G McLeod; Christopher Amling; Raymond Lance; John Foley; Wade Sexton; Leo Kusuda; Andrew Chung; Douglas Soderdahl; Timothy Donahue
Journal: J Urol Date: 2003-05 Impact factor: 7.450

5. Deaths: preliminary data for 2011.

Authors: Donna L Hoyert; Jiaquan Xu
Journal: Natl Vital Stat Rep Date: 2012-10-10

6. Prostate-cancer mortality at 11 years of follow-up.

Authors: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal: N Engl J Med Date: 2012-03-15 Impact factor: 91.245

7. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors: Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal: J Natl Cancer Inst Date: 2012-01-06 Impact factor: 13.506

8. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

Authors: Anthony V D'Amico; Ming-Hui Chen; Kimberly A Roehl; William J Catalona
Journal: N Engl J Med Date: 2004-07-08 Impact factor: 91.245

9. Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75.

Authors: Arthur A Caire; Leon Sun; Cary N Robertson; Thomas J Polascik; Kelly E Maloney; Daniel J George; Marva M Price; Danielle A Stackhouse; Benjamin D Lack; David M Albala; Judd W Moul
Journal: Urology Date: 2009-10-07 Impact factor: 2.649